Research and Development

The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl …

How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …

Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …

Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …

Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …

The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …